Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -306.90K | -358.30K | -415.10K | -427.90K | -276.70K |
| Total Depreciation and Amortization | 0.00 | 100.00 | 600.00 | 600.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 407.40K | 443.80K | 650.80K | 688.10K | 412.90K |
| Cash from Operations | 100.50K | 85.60K | 236.40K | 260.90K | 136.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 165.10K | 165.10K | 0.00 | 0.00 | -165.10K |
| Cash from Investing | 165.10K | 165.10K | 0.00 | 0.00 | -165.10K |
| Total Debt Issued | -289.40K | -289.40K | -289.40K | -289.40K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 3.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 16.20K | 16.20K |
| Cash from Financing | -289.40K | -289.40K | -289.40K | -273.20K | 19.60K |
| Foreign Exchange rate Adjustments | 21.70K | 35.80K | 43.90K | 12.80K | 12.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.20K | -3.00K | -9.20K | 500.00 | 3.60K |